NOVONIX Limited (ASX:NVX) (FRA:GC3) provides update regarding international trading in its shares following increasing levels of inbound enquiry from investors from North America and Europe during the month of June.
NOVONIX Limited (ASX:NVX) (FRA:GC3) wishes to advise it will host an investor webinar on Friday 12th June, 2020 at 10.15am AEST to discuss the recent announcement regarding its ability to manufacture single crystal NMC cathode material.
NOVONIX Limited (ASX:NVX) (FRA:GC3), in partnership with the Professor Mark Obrovac Research Group at Dalhousie University, is pleased to announce its ability to manufacture "single crystal" NMC cathode material using its proprietary Dry Particle Microgranulation (DPMG) technique.
NOVONIX Limited (ASX:NVX) (FRA:GC3) is conducting a fully underwritten ~$58.28 million equity raising
NOVONIX Limited (ASX:NVX) (FRA:GC3) is pleased to announce a significant $58.28 million capital raising, including a proposed institutional placement, a strategic placement and a rights issue to Australian and New Zealand NOVONIX shareholders, at an issue price of $0.29 per new share.
NOVONIX Limited (ASX:NVX) (FRA:GC3) is pleased to provide an update on breakthrough research coming from its research partnership with Prof. Mark Obrovac's group at Dalhousie University.
NOVONIX Limited (ASX:NVX) (FRA:GC3) hereby provides a specific COVID-19 Update in the context of the various government measures being implemented in the jurisdictions in which the Company operates.
